Ann: Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX, page-266

Just going back over earlier announcements re PD1-Vaxx. Over a year from when IMU escalated to the third dose, wow how time flies.

Apart from 1 pulling out, I assume 9/12, at a minimum, are still kicking around the 3rd rock from the sun. Stable disease affords a few more sunrises and sunsets. This is incredible news, from what I can gleam about Stage IV patients with NSCLC is they have a five-year relative survival rate of 7 percent.

This news should have been bundled into a release with all the fanfare that is deserves.

I seriously hope there is a follow up announcement with in depth findings from Phase 1. I believe it would be very poor of management not to do so and leave it at this. These announcements are golden opportunities to scream what we have from the roof tops and they are failing to do this. This was almost an accidental release. Come on team IMU, lets ensure we have some strategy behind our news flow. Is it time to appoint such a strategist?